Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The New Energy and Industrial Technology Development Organization (NEDO) is set to fund Activus Pharma, a wholly subsidiary of Sosei Group, for the 'Development of Innovative Ophthalmic Solutions' as a part of their FY2011 Innovation Promotion Programme.
Subscribe to our email newsletter
The grant is expected to fund two thirds of the development cost of the project.
Within this subsidized project, Activus will develop ophthalmic solutions that would differ from the existing treatments because they would be delivered to the posterior eye segment.
Up to two thirds of the development costs incurred for this project between 23 August 2011 and 28 February 2013 will be subsidized by the grant from NEDO.